Weight loss

Long-term obesity linked to expression of aging biomarkers

July 18, 2025 / Research update, Weight loss / InnovateMed Author / long term obesity

by Elana Gotkine edited by Gaby Clark, reviewed by Andrew Zinin Long-term obesity is associated with the expression of biomarkers denoting antagonistic and integrative aging hallmarks in adults aged 28 to 31 years, according to a study published online July 11 in JAMA Network Open. Paulina Correa-Burrows, Ph.D., from the Universidad de Chile, and colleagues examined the association between long-term […]

Long-term obesity linked to expression of aging biomarkers Read More »

How one elite rehab center is ‘obliterating’ all kinds of cravings with GLP-1s

July 14, 2025 / News update, Weight loss / InnovateMed Author / GLP 1

Rachel Wisniewski for STAT Ever since blockbuster weight loss medications burst on to the scene, GLP-1s have shown promise as not just a way to lose weight, but to revolutionize our understanding of desire. Early data showing the potential to treat addiction has been particularly exciting. But only a handful of clinical trials are underway, with several

How one elite rehab center is ‘obliterating’ all kinds of cravings with GLP-1s Read More »

The Undervalued Medical Power of Muscle

June 17, 2025 / Patient education, Weight loss / InnovateMed Author / GLP-1s, muscle, Skeletal muscle

The exponential rise of our aging population. The pandemic. The explosion of GLP-1s. It’s a trifecta that’s making muscle — and the serious implications of not having enough of it — part of a larger health conversation. Yet when I recently asked my 65-year-old mom whether her doctor had ever talked to her about resistance

The Undervalued Medical Power of Muscle Read More »

Wegovy and Mounjaro might affect how well your contraceptives work—here’s why

June 17, 2025 / Research update, Weight loss / InnovateMed Author / Wegovy and Mounjaro

by Simon Cork, The Conversation edited by Gaby Clark, reviewed by Andrew Zinin Editors’ notes Credit: Unsplash/CC0 Public Domain Weight loss drugs, including Wegovy (semaglutide) and Mounjaro (tirzepatide), are becoming increasingly popular among those trying to lose weight. But a rise in so-called “Ozempic babies” has led the UK’s medicines regulator to issue guidance on their use by women of reproductive age.

Wegovy and Mounjaro might affect how well your contraceptives work—here’s why Read More »

Long-term obesity linked to expression of aging biomarkers

How one elite rehab center is ‘obliterating’ all kinds of cravings with GLP-1s

The Undervalued Medical Power of Muscle

Wegovy and Mounjaro might affect how well your contraceptives work—here’s why

Need Help?

We are here to help.